The Efficacy of Pranayama in COPD
调息法对慢性阻塞性肺病的疗效
基本信息
- 批准号:8282238
- 负责人:
- 金额:$ 21.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenal Cortex HormonesAdverse effectsAirAnxietyBreathingBreathing ExercisesBronchodilator AgentsCause of DeathChronic Obstructive Airway DiseaseClinicalControlled Clinical TrialsDataDiseaseDouble-Blind MethodDyspneaEducationEducational process of instructingEffectivenessErythrocytesExerciseExercise ToleranceExhalationFunctional disorderFutureGlutathioneHealthHydrogen PeroxideInflammationInspiratory CapacityInterleukin-6InterventionLearningLip structureLungMeasuresMechanicsMethodsMulticenter TrialsOutcomeOutcome MeasureOxidative StressParticipantPatientsPatternPerformancePlasmaProteinsPsychological StressQuality of lifeQuestionnairesRandomizedRandomized Clinical TrialsRehabilitation therapyResearchRespiratory SystemRoleSerumShortness of BreathSiteStressSymptomsTechniquesTestingTimeTrainingWalkingWidthYogaabstractingclinical research sitecontrol trialdesignelectric impedancegroup interventionimprovedindexinginsightisoprostaglandin F2alpha type-IIIpranayamarespiratorytreatment as usual
项目摘要
DESCRIPTION (provided by applicant):
Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, and is currently the third leading cause of death in the United Sates. Patients with COPD mainly complain of shortness of breath with daily activities and exercise. A key mechanism of dyspnea is dynamic hyperinflation, or air trapping, which results from the severe airflow limitation that characterizes the disease. Inhaled bronchodilators and corticosteroids may help, but these therapies are expensive and may have side effects. Pulmonary rehabilitation is very effective at reducing dyspnea and improving exercise tolerance, but it is not widely available to patients. We propose studying the effect of a simple breathing exercise known as pranayama, or yogic breathing. Our hypothesis is that the practice of pranayama will improve exercise tolerance in patients with COPD. We believe that the mechanisms involved will include reduced dynamic hyperinflation as well as beneficial effects on lung mechanics, inflammation and oxidative stress. This hypothesis will be tested in a randomized, double blind, controlled trial of pranayama vs. usual care (education) in COPD patients. In Specific Aim 1, we will determine the effect of pranayama on exercise tolerance as measured by 6 min walk distance; in Specific Aim 2, we will determine the effect of pranayama on dynamic hyperinflation as measured by changes in inspiratory capacity before and after exercise; and in Specific Aim 3, we will determine the effect of pranayama on oxidative stress (exhaled breath H202, 8-isoprostane, glutathione), systemic inflammation (serum c-reactive protein, interleukin-6, glutathione and red cell distribution width), dyspnea level (Borg scale, MRC scale, BDI/TDI, CRQ), the BODE index, and quality of life (St. George Respiratory Questionnaire). The study is designed to be applicable to a wide variety of clinical settings, since it will involve two diverse clinical sites
(Burlington, VT and Houston, TX), require minimal direct intervention, and engage participants in self- learning and practice. The data from this study will provide fundamental new insights into
the mechanisms of action of pranayama, and will be critical in designing a large, multicenter trial
to test the effectiveness of pranayama in patients with COPD.
PUBLIC HEALTH RELEVANCE:
Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, and patients mainly suffer from severe shortness of breath with exercise. This study will investigate the effects of the practice of the yogic breathing method pranayama on exercise tolerance in patients with COPD. This intervention may prove to be an important adjunct to COPD therapy, since it is simple, inexpensive, and widely available.
(End of Abstract)
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David A Kaminsky其他文献
David A Kaminsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David A Kaminsky', 18)}}的其他基金
Spirometry to Motivate Quit-Smoking Attempts: Message Development and Testing
肺活量测定法激励戒烟尝试:消息开发和测试
- 批准号:
7484223 - 财政年份:2007
- 资助金额:
$ 21.4万 - 项目类别:
Spirometry to Motivate Quit-Smoking Attempts: Message Development and Testing
肺活量测定法激励戒烟尝试:消息开发和测试
- 批准号:
7315919 - 财政年份:2007
- 资助金额:
$ 21.4万 - 项目类别:
Spirometry to Motivate Quit-Smoking Attempts: Message Development and Testing
肺活量测定法激励戒烟尝试:消息开发和测试
- 批准号:
7665036 - 财政年份:2007
- 资助金额:
$ 21.4万 - 项目类别:
COBRE: UVT: AIRWAY PARENCHYMAL MECHANICAL DYSFUNCTION
COBRE:UVT:气道实质机械功能障碍
- 批准号:
7170235 - 财政年份:2005
- 资助金额:
$ 21.4万 - 项目类别:
COBRE: UVT: AIRWAY PARENCHYMAL MECHANICAL DYSFUNCT IN ASTHMA: PULMONARY, STEROID
COBRE:UVT:哮喘中的气道实质机械功能障碍:肺部,类固醇
- 批准号:
7011652 - 财政年份:2004
- 资助金额:
$ 21.4万 - 项目类别:
HYPERPNEA AND PARENCHYMAL PATHOPHYSIOLOGY IN ASTHMA
哮喘的呼吸过度和实质病理生理学
- 批准号:
2771169 - 财政年份:1995
- 资助金额:
$ 21.4万 - 项目类别:
HYPERPNEA AND PARENCHYMAL PATHOPHYSIOLOGY IN ASTHMA
哮喘的呼吸过度和实质病理生理学
- 批准号:
6056082 - 财政年份:1995
- 资助金额:
$ 21.4万 - 项目类别:
HYPERPNEA AND PARENCHYMAL PATHOPHYSIOLOGY IN ASTHMA
哮喘的呼吸过度和实质病理生理学
- 批准号:
2211776 - 财政年份:1995
- 资助金额:
$ 21.4万 - 项目类别:














{{item.name}}会员




